COMMUNIQUÉS West-GlobeNewswire

Début de la négociation des titres de Corporation Terranueva à la Bourse des valeurs canadiennes
17/12/2018
MONTRÉAL, 17 déc. 2018 (GLOBE NEWSWIRE) -- CORPORATION TERRANUEVA (la « Société » ou « Terranueva ») a annoncé que ses actions ordinaires (les « Actions ordinaires ») seront inscrites et commenceront à se négocier [...]
Hemispherx Biopharma Inc. Announces Updated Information about ME/CFS Expanded Access Program in the United States
17/12/2018
Highlights Include Visit with Patients in North Carolina OCALA, Fla., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company [...]
Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
17/12/2018
Seasoned veteran brings two decades of commercial experience to Acer Acer continues to execute on activities towards its goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics [...]
Uptick Newswire Hosts Progressive Care Inc’s CEO to Discuss an Exciting New Acquisition Prospect and Company Growth
17/12/2018
PHOENIX, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast features Progressive Care Inc. (OTCQB: RXMD), (The Company) a personalized healthcare services and technology company. CEO, Shital Mars, [...]
ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease
17/12/2018
MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that the U.S. [...]
Closing of the Transaction of $10,930,000 with Terranueva Pharma Corporation and Concurrent Private Placement of $2,310,000
17/12/2018
MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Terranueva Corporation (the “Corporation” or “Terranueva”) (CSE:TEQ) is pleased to announce the closing of a private placement and of the transaction of $10 930 000 with [...]
Clôture de la transaction de 10 930 000 $ avec Corporation Terranueva Pharma et d’un placement privé de 2 310 000 $
17/12/2018
MONTRÉAL, 17 déc. 2018 (GLOBE NEWSWIRE) -- Corporation Terranueva (la « Société » ou « Terranueva ») (CSE:TEQ) est heureuse d’annoncer la finalisation d’un placement privé et de la transaction de 10 930 000 $ avec [...]
Cutera Announces Expansion of FDA Indications for enlighten™ Laser Platform
17/12/2018
BRISBANE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
Physeon Bolsters Management Team with New Appointments
17/12/2018
Experienced Executives Join Physeon Team on Heels of Commencement of US VIVA Trial SCHAFFHAUSEN, Switzerland, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical [...]
The Governance Institute Announces Governance Technology Partnership with Nasdaq
17/12/2018
Provides membership access to Nasdaq’s next generation and award-winning board portal and collaboration software, Nasdaq Boardvantage® LINCOLN, Neb. and NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- The Governance [...]
Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019
17/12/2018
Preliminary top-line data from the alcoholic steatohepatitis (ASH) collaboration with Massachusetts General Hospital shows positive effect of larazotide on ethanol-induced permeability in vitro RALEIGH, N.C., Dec. 17, [...]
PotNetwork Holdings Inc. Prepares for Surge in Interstate Commerce Following 2018 US Hemp Farm Bill
17/12/2018
Industry-leading Subsidiary Diamond CBD Inc., Poised to Capture Evolving Consumer Market, Prepares for Revolutionary Industry Changes FORT LAUDERDALE, Fla., Dec. 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- [...]
Spectral Announces Results of a Face-to-Face meeting with the U.S. FDA
17/12/2018
TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
CLS Holdings USA Positioned for Growth in 2019
17/12/2018
LAS VEGAS, Dec. 17, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]
Cancer Genetics Terminates Proposed Merger with NovellusDx
17/12/2018
RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
17/12/2018
AC5™ provides a new option for the treatment of topical wounds FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and [...]
Acarix reports first patient enrollment in new clinical investigation exploring heart failure detection
17/12/2018
Press release Malmö, Sweden December 17, 2018 Acarix reports first patient enrollment in new clinical investigation exploring heart failure detection Acarix has initiated a new explorative clinical study to develop a [...]
Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2019.
17/12/2018
Latvia, 2018-12-17 13:34 CET (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2019: Consolidated not audited interim report for the 12 months of 2018 - 18.02. [...]
FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis
17/12/2018
U.S. Phase 2 Study to Begin in First Quarter of 2019 NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem cell [...]

Pages